Distinguished in Fructose-1,6-Bisphosphatase Deficiency

Anais Brassier

Paris, FR 
Distinguished in Fructose-1,6-Bisphosphatase Deficiency
Paris, FR 
OverviewLocationsClinical Research

Overview

Anais Brassier practices in Paris, France. Ms. Brassier is rated as a Distinguished expert by MediFind in the treatment of Fructose-1,6-Bisphosphatase Deficiency. Her top areas of expertise are Cholesteryl Ester Storage Disease, Wolman Disease, Lysosomal Acid Lipase Deficiency, Kidney Transplant, and Liver Transplant.

Her clinical research consists of co-authoring 99 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Fructose-1,6-Bisphosphatase Deficiency.

Gender
Female

Locations

Paris, France
Other Locations
Lyon, France
100 Boulevard Du Général Leclerc, Clichy-sous-bois, 92110, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency
Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency
Enrollment Status: Withdrawn
Publish Date: September 25, 2025
Intervention Type: Drug
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
Enrollment Status: Completed
Publish Date: November 19, 2024
Intervention Type: Drug
Study Drug: PEG-Zilarginase
Study Phase: Phase 3
MPS VI Clinical Surveillance Program (CSP)
MPS VI Clinical Surveillance Program (CSP)
Enrollment Status: Completed
Publish Date: April 05, 2021
View 2 Less Clinical Trials

99 Total Publications

Clinical, biochemical, and molecular findings in adults with hyperammonemia: A French bi-centric retrospective study.
Clinical, biochemical, and molecular findings in adults with hyperammonemia: A French bi-centric retrospective study.
Journal: Molecular genetics and metabolism
Published: April 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Brassier's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 21 Advanced Conditions
View All 49 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile